Suchergebnis | Hamburg Open Science

Facetten

35 Einträge gefunden

High levels of class III β-tubulin expression are associated with aggressive tumor features in breast cancer
2016 - Forschungsinformationssystem des UKE
Loss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancer
2016 - Forschungsinformationssystem des UKE
Cyclin D1 gene amplification is highly homogeneous in breast cancer
2016 - Forschungsinformationssystem des UKE
p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancer
2016 - Forschungsinformationssystem des UKE
Schnell wachsender Mammatumor der Stillphase
2014 - Forschungsinformationssystem des UKE
Loss of ALCAM expression is linked to adverse phenotype and poor prognosis in breast cancer: a TMA-based immunohistochemical study on 2,197 breast cancer patients
2014 - Forschungsinformationssystem des UKE
Mammographie-Screening. Ist was dran an der Kritik?
2014 - Forschungsinformationssystem des UKE
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.
2013 - Forschungsinformationssystem des UKE
German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer
2013 - Forschungsinformationssystem des UKE
[Breast cancer: current recommendations for pathologists on the basis of the S3 guidelines].
2013 - Forschungsinformationssystem des UKE
Rare oncogenic mutations of predictive markers for targeted therapy in triple-negative breast cancer.
2012 - Forschungsinformationssystem des UKE
Pathologic complete response after neoadjuvant chemotherapy plus trastuzumab predicts favorable survival in human epidermal growth factor receptor 2-overexpressing breast cancer: results from the TECHNO trial of the AGO and GBG study groups.
2011 - Forschungsinformationssystem des UKE
Reliability of human epidermal growth factor receptor 2 immunohistochemistry in breast core needle biopsies.
2010 - Forschungsinformationssystem des UKE
Immunohistochemistry and molecular analyses in myeloid sarcoma of the breast in a patient with relapse of NPM1-mutated and FLT3-mutated AML after allogeneic stem cell transplantation.
2010 - Forschungsinformationssystem des UKE
PPFIA1 and CCND1 are frequently coamplified in breast cancer.
2010 - Forschungsinformationssystem des UKE
Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome.
2010 - Forschungsinformationssystem des UKE
Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer.
2010 - Forschungsinformationssystem des UKE
Intensive dose-dense compared with conventionally scheduled preoperative chemotherapy for high-risk primary breast cancer.
2009 - Forschungsinformationssystem des UKE
Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose.
2009 - Forschungsinformationssystem des UKE
Overexpression of cell division cycle 7 homolog is associated with gene amplification frequency in breast cancer.
2009 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

High levels of class III β-tubulin expression are associated with aggressive tumor features in breast cancer

Loss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancer

Cyclin D1 gene amplification is highly homogeneous in breast cancer

p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancer

Schnell wachsender Mammatumor der Stillphase

Loss of ALCAM expression is linked to adverse phenotype and poor prognosis in breast cancer: a TMA-based immunohistochemical study on 2,197 breast cancer patients

Mammographie-Screening. Ist was dran an der Kritik?

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.

German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer

[Breast cancer: current recommendations for pathologists on the basis of the S3 guidelines].

Rare oncogenic mutations of predictive markers for targeted therapy in triple-negative breast cancer.

Pathologic complete response after neoadjuvant chemotherapy plus trastuzumab predicts favorable survival in human epidermal growth factor receptor 2-overexpressing breast cancer: results from the TECHNO trial of the AGO and GBG study groups.

Reliability of human epidermal growth factor receptor 2 immunohistochemistry in breast core needle biopsies.

Immunohistochemistry and molecular analyses in myeloid sarcoma of the breast in a patient with relapse of NPM1-mutated and FLT3-mutated AML after allogeneic stem cell transplantation.

PPFIA1 and CCND1 are frequently coamplified in breast cancer.

Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome.

Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer.

Intensive dose-dense compared with conventionally scheduled preoperative chemotherapy for high-risk primary breast cancer.

Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose.

Overexpression of cell division cycle 7 homolog is associated with gene amplification frequency in breast cancer.